Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Baxter

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Pageof 3